Lakefront Biotherapeutics NV annual gross margin
2021
2022
2023
2024
2025
Lakefront Biotherapeutics NV Gross Margin Growth & History (LKFT)
Lakefront Biotherapeutics NV's gross margin was 97.33% for fiscal 2025.
View full Lakefront Biotherapeutics NV company overviewLakefront Biotherapeutics NV annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 97.33% | +9.97 pp |
| 2024 | 2024-12-31 | 87.35% | −12.65 pp |
| 2023 | 2023-12-31 | 100.00% | +5.01 pp |
| 2022 | 2022-12-31 | 94.99% | −4.31 pp |
| 2021 | 2021-12-31 | 99.30% | — |
Lakefront Biotherapeutics NV gross margin trends
Between the periods ended 2021-12-31 and 2025-12-31, Lakefront Biotherapeutics NV's gross margin decreased from 99.30% to 97.33%, a change of −1.98 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lakefront Biotherapeutics NV source filings ↗